Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02274948Phase 4Completed
Phase 4, randomised, double-blind trial of liquid metformin (Aspargo Labs) in obesity (2 arms), sponsored by University of Colombo. Primary endpoints: Change in BMI Standard Deviation Score at 1 year and Change in Percentage Fat Mass Standard Deviation Score at 1 year. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02274948.